C R Vitt is an author at Novartis (China) specializing in medicine, immunology, and tumor biology.
Top concepts
MedicineImmunologyTumor BiologyPathologyCell BiologyInflammationPharmacologyTumor MicroenvironmentApoptosisCell Death
Publications per year
1987–2018
12
12
Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice.
H Y Min, Laura V. Doyle, C R Vitt et al. · PubMed · 1996 · 246 citations
Characterization of Novel Antimicrobial Peptoids
Bob Goodson, Anton F. Ehrhardt, Simon Ng et al. · Antimicrobial Agents and Chemotherapy · 1999 · 117 citations · Full text
Folkert Reck, Alun Bermingham, Johanne Blais et al. · Bioorganic & Medicinal Chemistry Letters · 2018 · 58 citations · Full text
Antimicrobial Drug Discovery, Antimicrobial Susceptibility, Health Sciences +12
Rows per page
1–5 of 12